- WHERE IS DENALI INCORPORATED?
- Denali Therapeutics Inc. was incorporated in Delaware in October 2013
- WHERE IS DENALI’S CORPORATE HEADQUARTERS?
- Denali is headquartered in South San Francisco, CA.
- WHEN IS DENALI’S FISCAL YEAR-END?
- Denali's fiscal year ends December 31st
- WHO IS DENALI’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM?
- Ernst & Young LLP is Denali's independent registered public accounting firm
- ON WHICH EXCHANGE IS DENALI LISTED, WHAT IS THE TICKER SYMBOL, AND WHEN DID DENALI GO PUBLIC?
- Denali is traded on the NASDAQ Global Select Stock Market under the ticker symbol "DNLI"
Denali initial public offering occurred on December 8, 2017
- WHAT IS THE CUSIP NUMBER FOR DENALI'S COMMON STOCK?
- 24823R 105
- WHO IS DENALI’S TRANSFER AGENT AND HOW DO I CONTACT THEM?
- American Stock Transfer & Trust Company
(800) 937-5449 (Toll-free)
(718) 921-8124 (International)
American Stock Transfer & Trust Company Operations Center
6201 15th Avenue
Brooklyn, NY 11219
- HOW CAN I GET A COPY OF YOUR ANNUAL REPORT OR OTHER PERIODIC REPORTS?
- Electronic copies of our Annual Report and other periodic reports are available on this website. If you would like to request paper copies of the Annual Report or other periodic reports, send your request in writing to:
Denali Therapeutics Inc.
Attn: Corporate Secretary
151 Oyster Point Blvd
South San Francisco, CA 94080
- HOW DO I CONTACT DENALI WITH ADDITIONAL QUESTIONS OR INQUIRIES?
- Please use the Investor Contact form at the bottom of the page for additional questions or inquiries.